SPECIAL SYMPOSIUM: INNOVATE: Innovative Neuromodulation for Veterans Research SS5

The Innovative Neuromodulation for Veterans Research (INNOVATE) Lab brings together neurorehabilitation researchers focused on improving complex chronic neuropsychiatric conditions among Veterans. We will highlight neuromodulation treatment development research utilizing transcranial magnetic stimulation (TMS). This presentation aims to demonstrate how TMS can be applied to improve functional outcomes among Veterans with complex chronic neuropsychiatric conditions including alcohol use disorder, mild traumatic brain injury and Parkinson’s disease. We will showcase innovative neuroscience-informed TMS treatment development for specific complex chronic neuropsychiatric conditions among Veterans. Dr. Amy Herrold will present multi-modal neuroimaging findings that informed neural target selection for an ongoing TMS RCT testing this custom neural target for co-occurring alcohol use disorder and mild traumatic brain injury (AUD+mTBI) to improve functional disability. Dr. Alexandra Aaronson will present her innovative TMS protocol to treat suicidality among Veterans with mTBI and negative urgency impulsivity based on the findings of her earlier work (Bernanke et al. 2024). Dr. Sandra Kletzel will present her RCT that utilizes TMS as a complementary treatment for cognitive rehabilitation for Veterans with mild cognitive impairment and Parkinson’s disease and related disorders (PD-MCI). All three researchers will demonstrate how the application of neuroscience was a key feature in the development and implementation of these studies. The INNOVATE Lab TMS protocols represent state of the art neuroscience-informed treatment development for neurorehabilitation of Veterans.